Munich — GSK Stock­mann advi­sed Opti­mas Group on the sale of its compa­nies in Germany, Italy, Belgium and Bulga­ria to Munich-based Accur­sia Capi­tal.

Opti­mas is the world’s leading indus­trial distri­bu­tor and service provi­der specia­li­zing in fastening and supply chain solu­ti­ons for manu­fac­tu­r­ers looking to improve effi­ci­ency and profi­ta­bi­lity. Opti­mas is owned by Ameri­can Indus­trial Part­ners, a New York (USA) based private equity firm focu­sed on the mid-cap segment.

The four compa­nies, with a total of around 230 employees and annual sales of around EUR 70 million, will operate under the name “Strong­hold” in the future.

Nunzi­ante Magrone Studio Legale Asso­ciato (Rome) advi­sed on the Italian legal aspects of the transaction.

Advi­sor Opti­mas Group: GSK Stockmann
Dr. Markus Söhn­chen (F’oto), Dr. Gerhard Gündel (Corporate/M&A), Domi­nik Berka (Tax), Dr. Phil­ipp Kuhn (Labor Law); Asso­cia­tes: Lieor Koblenz (Corporate/M&A), Nicole Depa­rade (Labor Law)

About Accur­sia Capital
Our stra­tegy pursues a long-term invest­ment hori­zon. The over­ri­ding objec­tive is to expand the indus­trial holding company by acqui­ring comple­men­tary compa­nies and to increase the compe­ti­ti­ve­ness of the indi­vi­dual holdings through syner­gies. Our invest­ment focus is on compa­nies with increased poten­tial for opera­tio­nal value growth.

We take respon­si­bi­lity for our port­fo­lio. We support our port­fo­lio compa­nies in all opera­tio­nal, finan­cial and stra­te­gic issues with the aim of incre­asing their compe­ti­ti­ve­ness and profi­ta­bi­lity. In addi­tion to capi­tal for invest­ment and growth, we support the manage­ment of the acqui­red compa­nies with exten­sive entre­pre­neu­rial experience.